Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02376699
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:11.548577+00:00
Published At
2023-05-01T00:00:00+00:00
Record Updated At
2023-05-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Carcinoma, Non-Small-Cell Lung", "Carcinoma, Squamous Cell", "Hodgkin Disease", "Lymphoma", "Lymphoma, B-Cell", "Lymphoma, Follicular", "Lymphoma, Large B-Cell, Diffuse", "Melanoma", "Neoplasm Metastasis", "Neoplasms, Head and Neck", "Neoplasms, Squamous Cell", "Non-Small Cell Lung Cancer", "Non-Small Cell Lung Cancer Metastatic", "Non-small Cell Carcinoma", "Squamous Cell Cancer", "Squamous Cell Carcinoma", "Squamous Cell Carcinoma of the Head and Neck", "Squamous Cell Neoplasm", "Lymphoma, Non-Hodgkin", "Pancreatic Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-01"
protocolSection.identificationModule.nctId
"NCT02376699"
protocolSection.identificationModule.officialTitle
"A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Carcinoma, Non-Small-Cell Lung (protocolSection.conditionsModule.conditions)
  • Carcinoma, Squamous Cell (protocolSection.conditionsModule.conditions)
  • Hodgkin Disease (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Lymphoma, B-Cell (protocolSection.conditionsModule.conditions)
  • Lymphoma, Follicular (protocolSection.conditionsModule.conditions)
  • Lymphoma, Large B-Cell, Diffuse (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Neoplasm Metastasis (protocolSection.conditionsModule.conditions)
  • Neoplasms, Head and Neck (protocolSection.conditionsModule.conditions)
  • Neoplasms, Squamous Cell (protocolSection.conditionsModule.conditions)
  • Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Non-Small Cell Lung Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • Non-small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Squamous Cell Cancer (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Squamous Cell Carcinoma of the Head and Neck (protocolSection.conditionsModule.conditions)
  • Squamous Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Lymphoma, Non-Hodgkin (protocolSection.conditionsModule.conditions)
  • Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.